Avalo Therapeutics AVTX
NASDAQ AVTX
$7.45 -4.81 (-39.23%)
At close: Oct 22, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Short-term Investments (2019 - 2026)

Updated

Avalo Therapeutics (AVTX) posted Short-term Investments of $314.89 million for Q2 2026, up 343.7% from $70.97 million a year earlier and up 452.4% from the prior quarter.

Analysis

Avalo Therapeutics (AVTX) Short-term Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Avalo Therapeutics' Short-term Investments came in at $82.48 million.

  • According to Business Quant data, Short-term Investments for the three prior quarters was $57.01 million (Q1 2026), $82.48 million (Q4 2025) and $84.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Avalo Therapeutics 303.91 Mn -388.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 314.89 Mn
Mar 31, 2026 57.01 Mn
Dec 31, 2025 82.48 Mn
Sep 30, 2025 84.65 Mn
Jun 30, 2025 70.97 Mn
Mar 31, 2020 14.71 Mn
Dec 31, 2019 7.63 Mn
API Access

Avalo Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=AVTX&period=max&api_key=YOUR_API_KEY